The ADDF accelerates the discovery of drugs to prevent and treat Alzheimer's disease through research funding and portfolio management.
The Alzheimer's Drug Discovery Foundation (ADDF) is dedicated to advancing the discovery of drugs to prevent and treat Alzheimer's disease. ADDF funds research programs focused on drug development, biomarkers, and prevention strategies. In 2024, ADDF catalyzed significant breakthroughs, including major investments in scalable blood tests and the cataloging of Alzheimer's biomarkers. The foundation also marked the 10th anniversary of the Goodes Prize and celebrated the FDA approval of Kisunla (Donanemab). ADDF's diverse portfolio is one of the largest worldwide, emphasizing lifestyle interventions and innovative diagnostics.
The Department of Psychological Sciences at Rice University uniquely blends the science of the human brain (e.g., researching the brain, memory, and language) with the science of human behavior and performance (e.g., researching effectiveness and satisfaction in educational and workplace settings). Our breadth of research interests creates a unique learning and research environment. The primary emphasis in the department is on research, in both the laboratory and applied settings.
The AIS eLibrary is a central repository for research papers and journal articles from the information systems academic community.
PSYCH OpenIR is the institutional repository of the Institute of Psychology, Chinese Academy of Sciences, providing access to research outputs and information on researchers' profiles and research directions.